Abstract
An ongoing clinical trial for anhedonia is evaluating the effectiveness of Behavioral Activation Treatment for Anhedonia (BATA) compared to Mindfulness-Based Cognitive Therapy (MBCT) in a transdiagnostic anhedonic sample (NCT04036136). The purpose of this study was to evaluate relations between treatment-related changes in anhedonia, measured by the Snaith-Hamilton Pleasure Scale (SHAPS), and changes in concurrent self-reported stress, measured by the Perceived Stress Scale (PSS) and PTSD Checklist for DSM-5 (PCL-5). Given evidence that stress alters reward sensitivity and contributes to the emergence of anhedonia, we hypothesize that participants reporting decreased anhedonia will also report reduced stress following treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
